Authorised spokespersons to communicate with the investment community
(including analysts, stockbrokers, individual and institutional
shareholders but excluding the media and rating agencies) are, unless
otherwise agreed, Executive Management and Investor Relations.
Investor Relations is to be present at all interactions between
company representatives and capital markets participants.
Investor Relations maintains an ongoing relationship with investors
and financial analysts. The primary channels for this comprise road
shows, broker conferences, Capital Market Days and thematic
presentations and conference calls.
Analyst meetings and conference calls arranged by Novo Nordisk to
discuss quarterly and annual financial performance, material business
events and thematic presentations will be simultaneously broadcasted
over the internet or via telephone conference call. Advance notice of
the meeting, and the simultaneous broadcast, will be made in a company
announcement or other method of communication.
Earnings company announcements will be released to newswires and
posted on Novo Nordisk’s corporate website at or prior to the
commencement of the meeting or call.
When asked to review analyst draft reports and financial models,
Investor Relations should limit review and comment to the following:
- Correcting historical factual information only
- Pointing out information that is in the public domain
- Discussing generally the factors that might influence the
underlying assumptions used for future projections